Polydeoxyribonucleotide Reduces Cytokine Production and the Severity of Collagen-Induced Arthritis by Stimulation of Adenosine A2A Receptor

被引：77

作者：

Bitto, Alessandra ^{[1
]}

Polito, Francesca ^{[1
]}

Irrera, Natasha ^{[1
]}

D'Ascola, Angela ^{[1
]}

Avenoso, Angela ^{[1
]}

Nastasi, Giancarlo ^{[1
]}

Campo, Giuseppe M. ^{[1
]}

Micali, Antonio ^{[1
]}

Bagnato, Gianfilippo ^{[1
]}

Minutoli, Letteria ^{[1
]}

Marini, Herbert ^{[1
]}

Rinaldi, Mariagrazia ^{[1
]}

Squadrito, Francesco ^{[1
]}

Altavilla, Domenica ^{[1
]}

机构：

[1] Univ Messina, Messina, Italy

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 11期

关键词：

ARTERY OCCLUSIVE DISEASE; RHEUMATOID-ARTHRITIS; HUMAN MONOCYTES; MICE; METHOTREXATE; INFLAMMATION; MECHANISMS; HMGB1; CIA; ANGIOGENESIS;

D O I：

10.1002/art.30538

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Objective. Broad antiinflammatory effects following adenosine A(2A) receptor stimulation have been demonstrated in acute inflammatory diseases, including arthritis. Polydeoxyribonucleotide (PDRN) activates the adenosine A(2A) receptor. This study was undertaken to investigate the effects of PDRN in collagen-induced arthritis (CIA) in mice. Methods. Arthritis was induced in DBA/1 mice by an intradermal injection of 100 mu l of bovine type II collagen in Freund's complete adjuvant. Mice were immunized a second time 21 days later. Control animals received 100 mu l of a saline solution. Animals with CIA were randomized to receive one of the following: vehicle (1 ml/kg); PDRN (8 mg/kg intraperitoneally daily); 3,7-dimethyl-propargylxanthine (DMPX), a specific adenosine A(2A) receptor antagonist (0.1 mg/kg intraperitoneally daily); or PDRN plus DMPX. The treatment was initiated immediately after the second immunization and continued to day 45. Clinical evaluation of arthritis was performed throughout the study. On day 45, the animals were killed and the severity of arthritis was evaluated histologically. Cartilage expression and circulating levels of high mobility group box chromosomal protein 1 (HMGB-1), tumor necrosis factor alpha (TNF alpha), interleukin-6 (IL-6), and IL-10 were investigated. Inflammatory cytokine production was also evaluated in stimulated human chondrocytes treated with PDRN. Results. PDRN treatment significantly ameliorated clinical signs of arthritis, improved histologic damage, reduced the cartilage expression and circulating levels of HMGB-1, TNF alpha, and IL-6, and enhanced IL-10 expression. The concomitant administration of DMPX and PDRN ablated the PDRN-induced protective effect in experimental arthritis. PDRN also reduced cytokine production from stimulated human chondrocytes. Conclusion. Our findings indicate that PDRN may represent a new alternative for the treatment of arthritis.

引用

页码：3364 / 3371

页数：8

共 33 条

[1]

Altavilla Domenica, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P313

[2]

HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis [J].